Tags : Cognoa

Weekly Snapshot

PharmaShots Weekly Snapshot (February 10-14, 2020)

1. Epizyme Reports the US FDA Acceptance of NDA for Tazverik (tazemetostat) to Treat Follicular Lymphoma Published: Feb 14, 2020 | Tags: Epizyme, Reports, US, FDA, Acceptance, NDA, Tazverik, tazemetostat, Follicular Lymphoma 2. Soligenix’s RiVax Receives the US FDA’s Fast Track Designation for the Prevention of Ricin Poisoning Published: Feb 13, 2020 | Tags: Soligenix, RiVax, Receives, […]Read More

Biotech

Cognoa Signs an Exclusive License Agreement with Stanford for its

Shots: Cognoa to get exclusive license rights for Stanford’s Google Glass-based autism technology to develop & commercialize digital therapies for children with autism spectrum disorder (ASD) The Superpower Glass (SG) intervention deployed via Google Glass and a mobile app is evaluated in 71 children with ASD and resulted in improvement in socialization, play and coping […]Read More